Activators of NBL4 play a significant role in the regulation of the erythrocyte membrane protein band 4.1 like 4A by employing a range of biochemical strategies. Certain molecules that act to either stimulate a particular enzyme responsible for synthesizing a key signaling molecule or inhibit enzymes that degrade this molecule are key in increasing its intracellular levels. The rise in this signaling molecule results in the activation of a kinase involved in a signaling pathway that influences the function of various proteins, including NBL4. Moreover, specific activators that target a group of receptors involved in cellular signaling can initiate a cascade of events leading to the production of this crucial signaling molecule, which is central to the kinase signaling pathway and may consequently promote the activation of NBL4. The interaction of these receptors with their natural or synthetic binders can similarly amplify NBL4 activity through this established route.
Additionally, strategies that involve the use of molecules that mimic the key signaling molecule and agents that can cause a lasting activation of signaling proteins illustrate another means of achieving NBL4 activation. These methods circumvent the usual receptor-mediated processes and provide a direct and sustained elevation in the signaling molecule's levels, thereby ensuring persistent kinase signaling activity. For example, certain toxins can lock a signaling protein subunit in an activated state, leading to an intensification of NBL4 activity. Likewise, compounds that act on specific receptors, and agents that target certain receptor agonists, further confirm the wide variety of molecules that can enhance NBL4 activation by focusing on the same signaling molecule-kinase axis.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Inhibits phosphodiesterase 4, leading to an increase in cAMP levels, thus potentially enhancing NBL4 activity by stimulating PKA signaling pathways. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Non-specific inhibitor of phosphodiesterases, raises intracellular cAMP levels, possibly resulting in the activation of NBL4 through PKA-dependent signaling mechanisms. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Activates adrenergic receptors which can lead to increased cAMP production and activation of PKA signaling, potentially enhancing NBL4 activity. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Beta-adrenergic agonist that increases cAMP levels and activates PKA signaling, which may contribute to the activation of NBL4. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Cell-permeable cAMP analog that activates PKA signaling, which could lead to the activation of NBL4. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
Through its action on H2 receptors, it can increase cAMP levels, thereby possibly activating NBL4 through PKA-dependent pathways. | ||||||
Adenosine | 58-61-7 | sc-291838 sc-291838A sc-291838B sc-291838C sc-291838D sc-291838E sc-291838F | 1 g 5 g 100 g 250 g 1 kg 5 kg 10 kg | $34.00 $48.00 $300.00 $572.00 $1040.00 $2601.00 $4682.00 | 1 | |
Acts on A2 receptors to increase cAMP levels, potentially leading to the activation of NBL4 through PKA signaling pathways. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Through EP2 and EP4 receptors, increases cAMP levels in cells, which may contribute to the activation of NBL4 via PKA signaling. | ||||||
BAY 60-6583 | 910487-58-0 | sc-503262 | 10 mg | $210.00 | ||
A2B adenosine receptor agonist which enhances cAMP production, potentially leading to the activation of NBL4 through PKA-dependent signaling pathways. | ||||||